Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial



Neoptolemos, John P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ghaneh, Paula, Psarelli, Eftychia E ORCID: 0000-0002-3102-0288, Valle, Juan W, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Faluyi, Olusola, O'Reilly, Derek A, Cunningham, David, Wadsley, Jonathan
et al (show 25 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. LANCET, 389 (10073). 1011 - 1024.

[img] Text
ESPAC-4 Lancet 2017.pdf - Published Version

Download (496kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 02 Feb 2017 14:04
Last Modified: 28 Nov 2019 09:46
DOI: 10.1016/S0140-6736(16)32409-6
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3005541
Repository Staff Access